Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maddalena Castellani Pastoris is active.

Publication


Featured researches published by Maddalena Castellani Pastoris.


Journal of Immunology | 2004

Type I IFN Protects Permissive Macrophages from Legionella pneumophila Infection through an IFN-γ-Independent Pathway

Giovanna Schiavoni; Claudia Mauri; Davide Carlei; Filippo Belardelli; Maddalena Castellani Pastoris; Enrico Proietti

Legionella pneumophila is an intracellular pathogen whose replication in macrophages is mainly controlled by IFN-γ. Freshly isolated peritoneal macrophages elicited in vivo with thioglycolate (TG) from A/J mice are highly permissive to L. pneumophila growth in vitro, while TG-elicited macrophages from CD1 mice are resistant. In this study, we show that when CD1 TG-macrophages are cultured for 7 days, they become permissive to Legionella infection. We demonstrate that treatment with type I IFN (IFN-αβ) totally inhibits the growth of L. pneumophila in both freshly isolated A/J and in vitro-aged CD1 TG-macrophages. IFN-αβ protective effect on permissive macrophages was comparable to that induced by IFN-γ. Even low doses of either IFN-α or IFN-β alone were effective in inhibiting L. pneumophila multiplication in macrophage cultures. Notably, treatment of resistant, freshly isolated CD1 TG-macrophages with Ab to mouse IFN-αβ significantly enhanced their susceptibility to Legionella infection in vitro, thus implying a role of endogenous IFN-αβ in mediating the natural resistance of macrophages to L. pneumophila infection. Finally, addition of anti-IFN-γ-neutralizing Ab did not restore Legionella growth in IFN-α- or IFN-β-treated A/J or CD1 permissive macrophages, indicating that IFN-αβ effect was not mediated by IFN-γ. This observation was further confirmed by the finding that IFN-αβ was effective in inhibiting L. pneumophila replication in macrophages from IFN-γ receptor-deficient mice. Taken together, our results provide the first evidence for a role of IFN-αβ in the control of L. pneumophila infection in mouse models of susceptible macrophages and suggest the existence of different pathways for the control of intracellular bacteria in macrophages.


Scandinavian Journal of Infectious Diseases | 1988

A Family Cluster of Legionella pneumophila Infections

Maddalena Castellani Pastoris; Egidio F. Viganò; Carla Passi

Three members of one single family of 4, the father, a son and a daughter, showed seroconversion against Legionella pneumophila serogroup 1 (Lp SG1). The son had a severe pneumonia, whereas the father and the daughter did not develop any other illness than mild and transient fever. A fourth member, the mother, remained seronegative. Lp SG1 was detected by a direct immunofluorescence test in water samples from the shower at home, in tap water in the familys butcher shop, and in condensation water from the ventilator of refrigerator cells in the shop. Two different sources of infection appear to have occurred: showering at home and an aerosol of contaminated condensation water. Reports of more than one case of legionella infection within a family seem to be extremely rare and have not been found in the literature.


Italian Journal of Public Health | 2007

Legionella pneumophila serogroup 5 infection in the presence of multiple environmental contamination. The importance of a bacteriological diagnosis

Maria Teresa Montagna; Maria Luisa Ricci; Christian Napoli; Daniela Tat; Maria Scaturro; Giovanna Barbuti; Giuseppe Pierucci; Maddalena Castellani Pastoris

Legionella pneumophila is a pathogen that causes severe pneumonia in humans; L. pneumophila serogroup 1 accounts for at least 90% of infections. This is not linked to an environmental predominance of Legionella pneumophila 1, but may be due to a greater virulence of the strain. L. pneumophila sg 5 has also been reported, albeit less frequently, to be a cause of the disease. We report a case of L. pneumophila sg 5 occurring in a large hospital in southern Italy (Apulia region), where both L. pneumophila sg 1 and sg 5 were detected in the water supply; the nosocomial origin was demonstrated by molecular subtyping (PFGE). An environmental investigation, performed immediately after diagnosis of the case of legionellosis, identified a ow L. pneumophila sg 5 contamination level. Our experience highlights that in hospital, risk assessment, in rder to institute control measures for Legionella, should be carried out not only in response to a case of the disease and/or in risk wards only, as described in the Italian Guidelines, but periodically in every ward. The present study confirms that, although in the community L. pneumophila sg 1 is the most frequent strain isolated in both outbreaks and isolated cases, in hospital other serogroups and species may often cause infection because of the high susceptibility of the hosts.


Microbiology and Immunology | 1998

Multiplication of Legionella pneumophila in HeLa cells in the presence of cytoskeleton and metabolic inhibitors

Paola Goldoni; L. Cattani; Stefania Carrara; Maddalena Castellani Pastoris; L. Sinibaldi; N. Orsi

A study has been carried out on the action of cytoskeleton and metabolic inhibitors on intracellular multiplication in HeLa cells of a virulent strain of Legionella pneumophila serogroup 6. The effects of the substances were separately tested on both penetration and intracellular multiplication of L. pneumophila. Only cytochalasin A and 2‐deoxy‐d‐glucose (2dG) affected bacterial internalisation, whereas intracellular multiplication was inhibited by cytochalasins A, B, C, D and J (D being the most active) and by 2dG with a dose‐response effect. The action of 2dG was counteracted by 50 mM glucose. Experiments carried out with cytochalasin D and a rhodamine‐phalloidin conjugate showed the involvement of cytoskeletal elements in intracellular multiplication of Legionella; compounds acting on microtubules had no effect.


Journal of Clinical Microbiology | 1997

Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups.

Jürgen H. Helbig; J B Kurtz; Maddalena Castellani Pastoris; C Pelaz; Paul Christian Lück


Clinical Microbiology and Infection | 1999

A multicenter evaluation of genotypic methods for the epidemiologic typing of Legionella pneumophila serogroup 1: results of a pan-European study

Norman K. Fry; Stella Alexiou-Daniel; Jette Marie Bangsborg; Sverker Bernander; Maddalena Castellani Pastoris; Jerome Etienne; Benita Forsblom; Valeria Gaia; Jörgen H. Helbig; Diane Lindsay; P. Christian Löck; Carmen Pelaz; Søren A. Uldum; Timothy G. Harrison


Journal of Clinical Microbiology | 1999

Multiple types of Legionella pneumophila serogroup 6 in a hospital heated-water system associated with sporadic infections.

Paolo Visca; Paola Goldoni; P. Christian Lück; Jürgen H. Helbig; L. Cattani; Giuseppe Giltri; Simone Bramati; Maddalena Castellani Pastoris


Clinical Infectious Diseases | 1999

Legionnaires' Disease on a Cruise Ship Linked to the Water Supply System: Clinical and Public Health Implications

Maddalena Castellani Pastoris; Renato Lo Monaco; Paola Goldoni; Bruno Mentore; Giacomo Balestra; Lorenzo Ciceroni


Vaccine | 2005

Induction of protective immunity by Legionella pneumophila flagellum in an A/J mouse model.

Maria Luisa Ricci; Antonella Torosantucci; Maria Scaturro; Paola Chiani; Lucilla Baldassarri; Maddalena Castellani Pastoris


Journal of Medical Microbiology | 1991

Growth of Legionella spp. under conditions of iron restriction

Paola Goldoni; Paolo Visca; Maddalena Castellani Pastoris; Piera Valenti; N. Orsi

Collaboration


Dive into the Maddalena Castellani Pastoris's collaboration.

Top Co-Authors

Avatar

Maria Luisa Ricci

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Paola Chiani

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paola Goldoni

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Lucilla Baldassarri

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Maria Scaturro

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

L. Cattani

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

N. Orsi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jürgen H. Helbig

Dresden University of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge